Related by context. All words. (Click for frequent words.) 74 docetaxel 71 bendamustine 70 rituximab 70 gemcitabine 70 FOLFOX 70 dacarbazine 70 vandetanib 70 tocilizumab 70 active comparator 69 temsirolimus 69 tolerability 69 sorafenib 69 FOLFIRI 69 fluconazole 69 etanercept 68 Fludara 68 mg dose 68 pemetrexed 68 dexamethasone 68 adalimumab 68 sunitinib 68 metastatic renal cell carcinoma 68 bortezomib 68 cytarabine 68 vinorelbine 68 carboplatin paclitaxel 68 dasatinib 68 mRCC 68 TORISEL 67 TMC# [001] 67 ritonavir boosted 67 Peg IFN 67 lamivudine 67 infliximab 67 APTIVUS 67 APTIVUS r 67 mg BID 67 peginterferon alfa 2b 67 azathioprine 67 metformin 67 azacitidine 67 protease inhibitor PI 67 PREZISTA r 67 pegylated interferon 67 Pegasys ® 67 chlorambucil 67 plus dexamethasone 67 lopinavir r 67 boosted protease inhibitor 66 imatinib 66 Taxotere ® 66 methotrexate MTX 66 docetaxel chemotherapy 66 plus gemcitabine 66 Amrubicin 66 tiotropium 66 Torisel 66 carboplatin 66 bevacizumab 66 abatacept 66 tenofovir emtricitabine 66 lopinavir ritonavir 66 mg QD 66 mcg kg 66 glatiramer acetate 66 peg IFN 66 raltegravir 66 mapatumumab 66 teriflunomide 66 RoACTEMRA 66 nab paclitaxel 66 tipranavir 66 sorafenib Nexavar 66 lacosamide 66 CHOP chemotherapy 66 plus ribavirin 66 DMARD 66 indacaterol 66 TNF inhibitor 66 administered subcutaneously 66 insulin glargine 66 visilizumab 65 pertuzumab 65 decitabine 65 ISENTRESS 65 Taxotere 65 peginterferon alfa 65 Targretin 65 trastuzumab 65 leucovorin 65 TNF antagonists 65 mycophenolate mofetil 65 ELOXATIN 65 SCH # 65 sapacitabine 65 HER2 positive metastatic breast 65 unfractionated heparin 65 peginterferon alfa 2a 65 topotecan 65 VELCADE 65 sitagliptin 65 SYMBICORT 65 temozolomide 65 mg doses 65 FOLFOX6 65 JANUVIA 65 allopurinol 65 darunavir ritonavir 65 DMARDs 65 peginterferon 65 SEROQUEL XR 65 alfa 2a 65 pomalidomide 65 valsartan 65 methotrexate 65 goserelin 65 pegylated liposomal doxorubicin 65 irinotecan 65 amrubicin 65 LEXIVA 65 bosentan 65 infusional 5-FU/LV 65 pioglitazone 65 irbesartan 65 lenalidomide 65 mitoxantrone 65 basal insulin 65 ATACAND 64 CIMZIA TM 64 sunitinib malate 64 PEGINTRON 64 idraparinux 64 capecitabine 64 low dose cytarabine 64 ribavirin RBV 64 insulin detemir 64 Elitek 64 interferon alfa 64 interferon alfa 2b 64 pegylated interferon alfa 2a 64 dose regimens 64 ixabepilone 64 estramustine 64 tolerability profile 64 VELCADE melphalan 64 docetaxel Taxotere 64 oxaliplatin 64 Laquinimod 64 pegylated interferon alpha 64 lispro 64 amlodipine 64 Tarceva TM 64 surrogate endpoint 64 ACTEMRA TM 64 phase IIb clinical 64 darunavir 64 5-FU/LV 64 aliskiren 64 YONDELIS 64 anti TNF 64 oral antidiabetic agents 64 Pegasys peginterferon alfa 2a 64 forodesine 64 vicriviroc 64 LPV r 64 Ribavirin 64 cetuximab 64 subcutaneous formulation 64 G CSF 64 erlotinib Tarceva ® 64 Taxotere R 64 antihypertensive agents 64 stavudine 64 relapsed refractory multiple myeloma 64 RG# [001] 64 pazopanib 64 #mg dose [003] 64 Jevtana 64 elotuzumab 64 metastatic hormone refractory 64 erlotinib 64 TYKERB 64 DOXIL 63 eltrombopag 63 evaluating tivozanib 63 AZILECT 63 zoledronic acid 63 antiepileptic drug 63 atazanavir 63 galiximab 63 TRIZIVIR 63 dose cohorts 63 axitinib 63 angiotensin receptor blocker ARB 63 NOXAFIL 63 NRTIs 63 amphotericin B 63 AGILECT R 63 ABC/3TC 63 interferon gamma 1b 63 dabigatran etexilate 63 paclitaxel carboplatin 63 abacavir lamivudine 63 TDF FTC 63 LEXIVA r 63 Pegasys plus Copegus 63 Aptivus ® 63 sorafenib Nexavar ® 63 refractory AML 63 lapatinib Tykerb 63 idarubicin 63 daunorubicin 63 HuMax CD4 63 anakinra 63 rilpivirine 63 subcutaneously administered 63 chemoradiotherapy 63 lenalidomide dexamethasone 63 palonosetron 63 metformin sulfonylurea 63 adalimumab Humira 63 bevacizumab Avastin 63 imatinib mesylate 63 nitazoxanide 63 HGS ETR1 63 #mg/m# [001] 63 budesonide 63 advanced NSCLC 63 anti leukemic 63 nilotinib 63 fluorouracil 63 xanthine oxidase inhibitor 63 REBETOL 63 #mg doses [002] 63 #mg/m# [002] 63 XGEVA 63 FOLOTYN 63 FOLFOX4 63 COPEGUS 63 INCB# [001] 63 5 fluorouracil 63 posaconazole 63 quetiapine 63 primary hypercholesterolemia 63 oral rivaroxaban 63 virologic failure 63 Copegus ribavirin 63 standard chemotherapy regimen 63 dose dexamethasone 63 mTOR inhibitor 63 HGS# 63 thiazolidinedione 63 valopicitabine 63 atazanavir ritonavir 63 desvenlafaxine succinate 63 dose cytarabine 63 HRPC 63 glufosfamide 63 pegylated interferon alfa 63 adefovir 63 DMARDS 63 perifosine 63 BARACLUDE ® 63 lamotrigine 63 calcineurin inhibitors 63 Traficet EN 63 polymerase inhibitor 63 oral diclofenac 63 glargine 63 aripiprazole 63 protease inhibitor 63 entecavir 63 #mg/day [001] 63 disease modifying antirheumatic 63 PEG Interferon lambda 63 ARIXTRA 63 hormone refractory prostate cancer 63 antithrombotic 63 CANCIDAS 63 relapsed multiple myeloma 62 plus prednisone 62 ERBITUX 62 comparator arm 62 nucleoside analog 62 Clolar 62 AGILECT ® 62 melphalan prednisone 62 fondaparinux 62 calcineurin inhibitor 62 oral antidiabetic 62 cabazitaxel 62 relapsed MM 62 INTELENCE 62 PRISTIQ 62 tenofovir Viread 62 cisplatin 62 levetiracetam 62 Dasatinib 62 tamsulosin 62 Epivir 62 sorafenib tablets 62 VAPRISOL 62 nelfinavir 62 dexamethasone Decadron 62 atypical antipsychotic 62 aflibercept 62 OADs 62 DAPT 62 hour bronchodilation 62 interferon alfa 2a 62 clofarabine 62 metastatic colorectal cancer 62 μg dose 62 gemcitabine chemotherapy 62 Phase 2a trial 62 virological failure 62 PEG IFN 62 dose regimen 62 HUMIRA 62 biologic therapy 62 cell lymphoma CTCL 62 subcutaneous SC 62 tenofovir DF 62 levosimendan 62 Irinotecan 62 placebo 62 relapsed refractory 62 pegylated interferon alfa 2b 62 lenalidomide Revlimid R 62 intermittent dosing 62 ACTEMRA 62 alvimopan 62 nucleoside analogue 62 Phase 2b study 62 glucose lowering 62 BRIM2 62 TMC# C# 62 Cimzia ® 62 AEGR 62 indolent NHL 62 VIRAMUNE 62 fluticasone 62 weekly subcutaneous injections 62 ibandronate 62 PegIntron 62 celgosivir 62 Onbrez Breezhaler 62 remission induction 62 MabCampath 62 pegfilgrastim 62 EFAPROXYN 62 DMARD therapy 62 TYGACIL 62 Omacetaxine mepesuccinate 62 REVLIMID 62 Lantus R 62 mg kg dose 62 Darunavir 62 CAELYX 62 cetuximab Erbitux ® 62 romiplostim 62 achieved ACR# 62 VIDAZA 62 interferon beta 1a 62 PD LID 62 ENBREL 62 salmeterol fluticasone 62 #mg QD [001] 62 mcg dose 62 ONGLYZA ™ 62 dose escalation 62 lapatinib 62 telbivudine 62 dosage regimens 62 maraviroc 62 NNRTI 62 clodronate 62 integrase inhibitor 62 APPRAISE 62 Vectibix 62 adjunctive therapy 62 VFEND 62 gemcitabine Gemzar ® 62 FOLPI 62 immunomodulatory therapy 62 neratinib 62 non metastatic osteosarcoma 62 Folfox 62 citalopram 62 rNAPc2 61 Phase Ib 61 interferon 61 Monotherapy 61 dosing regimens 61 tenofovir disoproxil fumarate 61 Mylotarg 61 fludarabine 61 ARCOXIA 61 pegylated 61 ritonavir boosted atazanavir 61 viral kinetics 61 CoFactor 61 5 FU 61 adecatumumab 61 AZILECT R 61 Hycamtin ® 61 Revlimid lenalidomide 61 6R BH4 61 divalproex sodium 61 Ceflatonin 61 LMWH 61 glimepiride 61 cangrelor 61 REMICADE ® 61 REYATAZ r 61 NVA# 61 Phase Ib II 61 INCB# [002] 61 peg interferon 61 epoetin alfa 61 TNF inhibitors 61 KOMBIGLYZE XR 61 octreotide 61 eptifibatide 61 Erlotinib 61 divalproex 61 antitumor activity 61 etoposide 61 REYATAZ R 61 saquinavir 61 Tarceva erlotinib 61 fluoropyrimidine 61 metformin HCl 61 CYT# 61 olmesartan 61 tolvaptan 61 dasatinib Sprycel ® 61 diabetic neuropathic pain 61 octreotide LAR 61 ramipril 61 bosutinib 61 stavudine d4T 61 sulfonylurea 61 Sandostatin LAR 61 certolizumab 61 iniparib 61 follicular NHL 61 sulphonylurea 61 Tarceva 61 darunavir r 61 ofatumumab 61 IIIa inhibitor 61 HyQ 61 trabectedin 61 Navelbine 61 fluticasone furoate 61 investigational compound 61 HAART regimens 61 antihypertensive drugs 61 pramlintide 61 generation purine nucleoside 61 VPRIV 61 sipuleucel T 61 refractory NSCLC 61 ZYBRESTAT 61 docetaxel Taxotere ® 61 gefitinib 61 methotrexate monotherapy 61 zalutumumab 61 NATRECOR R 61 interferon alpha 61 lixisenatide 61 ONGLYZA 61 metastatic castration resistant 61 FROVA 61 fulvestrant 61 tolerability profiles 61 Arixtra 61 metaglidasen 61 DU #b 61 leukemia AML 61 febuxostat 61 etravirine 61 tipranavir r 61 Clevudine 61 telaprevir dosed 61 evaluable patients 61 doxorubicin docetaxel 61 Ixempra 61 Eltrombopag 61 cutaneous T cell 61 ceftriaxone 61 ELACYT 61 aprepitant 61 ZYVOX 61 PROMACTA 61 rasagiline 61 Perforomist TM Inhalation Solution 61 enzastaurin 61 RLAI 61 #mg QD [002] 61 bivalirudin 61 daclizumab 61 refractory acute myeloid 61 antidiabetic 61 phase Ib 61 ritonavir 61 paclitaxel Taxol 61 intravenous dosing 61 paliperidone palmitate 61 HCV SPRINT 61 Gemzar ® 61 ziprasidone 61 OPAXIO 61 EGFR TKI 61 4mg/kg 61 abiraterone acetate 61 oral ridaforolimus 61 doxorubicin HCl liposome injection 61 perampanel 61 placebo dexamethasone 61 QVA# 61 Gemcitabine 61 EGFR expressing mCRC 61 vidofludimus 61 elacytarabine 61 sustained virologic response 61 LIALDA 61 panitumumab 61 eculizumab 61 fosamprenavir 61 ambrisentan 61 Adalimumab 61 Bortezomib 61 TEMODAL 61 adjuvant therapy 61 relapsing multiple sclerosis 61 ORENCIA ® 61 IRESSA 61 paliperidone ER 61 Phase 1b 61 mcg albinterferon alfa 2b 61 dose cohort 60 imatinib Gleevec ® 60 rHuPH# 60 ribavirin therapy 60 tanespimycin 60 Bevacizumab 60 lintuzumab 60 mg/m2 60 Dacogen injection 60 ticagrelor 60 REVLIMID ® 60 Dabigatran etexilate 60 Cloretazine 60 clozapine 60 hypercalcemia 60 crizotinib PF # 60 chemotherapy regimens 60 mg d 60 recurrent glioblastoma multiforme 60 SEROQUEL 60 CIMZIA 60 #mg BID [003] 60 caspofungin 60 factor Xa inhibitor 60 randomized 60 oral allopurinol 60 low dose dexamethasone 60 anthracycline taxane 60 RSD# 60 3TC lamivudine Epivir 60 evaluable 60 Pemetrexed 60 bevacizumab Avastin ® 60 Tykerb 60 Combination therapy 60 cediranib 60 Phase 1b clinical 60 Noxafil 60 TELCYTA 60 insulin lispro 60 heavily pretreated 60 chronic lymphocytic leukemia CLL 60 COPAXONE R 60 picoplatin 60 TAXOTERE R 60 abatacept Orencia 60 maximally tolerated dose 60 docetaxel Taxotere R 60 TELINTRA 60 administered orally 60 evaluating REVLIMID 60 riociguat 60 interferon beta 1b 60 uric acid lowering 60 8mg/kg 60 oxaliplatin Eloxatin 60 PREZISTA 60 LATUDA 60 NEUPOGEN 60 imatinib resistant 60 ASA# 60 Atacand 60 Velcade bortezomib 60 5FU 60 motesanib 60 piperacillin tazobactam 60 rivaroxaban 60 TREDAPTIVE 60 CCR5 antagonist 60 thalidomide Thalomid 60 infliximab Remicade 60 Capecitabine 60 Topotecan 60 BRAF inhibitor 60 receptor tyrosine kinase inhibitor 60 heavily pretreated patients 60 ZOLINZA 60 MYLOTARG 60 T DM1 60 partial remissions 60 HCV RESPOND 2 60 ABILIFY 60 RRMS patients 60 symptomatic BPH 60 oblimersen 60 aripiprazole Abilify 60 Perforomist Inhalation Solution 60 trastuzumab Herceptin R 60 low dose ritonavir 60 tacrolimus ointment 60 Targretin capsules 60 Doxil 60 ribavirin 60 gemcitabine cisplatin 60 ACZ# 60 fluorouracil leucovorin 60 antiplatelet agent 60 Dapagliflozin 60 unresectable 60 lumiliximab 60 Certolizumab pegol 60 refractory CTCL 60 thymalfasin 60 biphasic insulin aspart 60 alpha 2a 60 inhaled corticosteroid 60 PEG INTRON 60 GnRH agonist 60 paricalcitol 60 SPRYCEL ® 60 sertraline 60 HMG CoA reductase inhibitor 60 canakinumab 60 leukotriene receptor antagonist 60 telcagepant 60 Lenalidomide 60 relapsing remitting multiple sclerosis 60 Free Survival PFS 60 multicenter randomized placebo controlled 60 Rebif ® 60 PEGINTRON TM 60 Lamictal XR 60 cART 60 beta2 agonist 60 antiviral activity 60 Nexavar ® 60 Herceptin trastuzumab 60 CRp 60 formoterol fumarate 60 dosing schedules 60 pemetrexed Alimta 60 investigational oral 60 imatinib therapy 60 long acting muscarinic 60 inhibitor RG# 60 granisetron 60 brivaracetam 60 mg/m2 dose 60 Doxil ® 60 fostamatinib 60 placebo intravenously 60 Tamibarotene 60 INVEGA ® 60 CLARITY study 60 investigational protease inhibitor 60 angiotensin converting enzyme inhibitor 60 tesmilifene 60 Gefitinib 60 abacavir 60 Increlex ® 60 Phase 1b trial 60 antiretroviral agents 60 timolol 60 alvespimycin 60 phase IIb trial 60 adjunctive treatment 60 Victoza R 60 epoetin 60 efavirenz EFV 60 XELOX 60 BAY #-# 60 median PFS 60 albinterferon alfa 2b 60 antihypertensive therapy 60 chemotherapeutic agent 60 BEACOPP 60 apremilast 60 Cimzia TM 60 efficacy tolerability 60 oral dosing 60 FTY# fingolimod 60 bortezomib Velcade R 60 bicifadine 60 ULORIC 60 immunomodulator 60 oral vancomycin 60 PROCRIT 60 Femara letrozole 60 alkylating agent 60 dose escalation trial 60 Pharmacokinetics PK 60 docetaxel prednisone 60 Fludara ® 60 baminercept 60 antiarrhythmic drug 60 telaprevir 60 S/GSK# 60 free survival PFS 60 neurologic progression 60 tirofiban 60 RezularTM 60 flutamide 60 AZT zidovudine Retrovir 60 Phase Ib clinical 60 Fludarabine 60 mirtazapine 60 PREZISTA ritonavir 60 EOquin 60 Tasigna 60 beclomethasone dipropionate 60 secondary efficacy endpoints 60 levofloxacin 60 zidovudine AZT 60 Taxotere docetaxel 60 antiandrogen 60 SPRYCEL 60 bicalutamide 60 TNF alpha inhibitor 60 Telintra 60 NPH insulin 60 amoxicillin clavulanate 60 superficial bladder cancer 59 lamivudine 3TC 59 thalidomide dexamethasone 59 gemcitabine carboplatin 59 Vimpat ® 59 efalizumab 59 phase IIa clinical 59 pharmacokinetics PK 59 ACE inhibitor ramipril 59 peginterferon alpha 2a 59 cytarabine daunorubicin 59 dose escalation clinical 59 chemoradiation 59 MAGE A3 ASCI 59 rFVIIa 59 metastatic HRPC 59 subcutaneous injections 59 romidepsin 59 Cladribine Tablets 59 Navelbine ® 59 CIMZIA ™ 59 clinically meaningful 59 Nexavar sorafenib 59 paclitaxel 59 PREZISTA rtv 59 bipolar mania 59 enoxaparin 59 montelukast 59 TMC# [002] 59 atypical antipsychotic medication 59 lipid lowering agents 59 safinamide 59 placebo controlled clinical trials 59 metastatic RCC 59 double blinded placebo 59 cetuximab Erbitux 59 ganetespib 59 #mg BID [001] 59 VIRAMUNE XR 59 Xanafide 59 amprenavir 59 oral anticoagulant 59 platinum refractory 59 Aptivus 59 mometasone furoate 59 OncoVEX GM CSF 59 GW# [003] 59 eribulin mesylate 59 IXEMPRA 59 cilengitide 59 Lacosamide 59 Vaprisol 59 diagnosed multiple myeloma 59 ZD# [001] 59 carbidopa levodopa 59 placebo controlled clinical 59 neoadjuvant 59 refractory CLL 59 methylnaltrexone 59 Raptiva ® 59 relapsed ovarian cancer 59 unfractionated heparin UFH 59 talabostat 59 telmisartan 59 Reverset 59 gemcitabine Gemzar 59 ketoconazole 59 rhGH 59 potent CYP#A# inhibitors 59 noninferiority 59 #mg dose [001] 59 IFN beta 59 valproate 59 CTAP# Capsules 59 relapsing remitting MS 59 aldosterone antagonists 59 Xeloda 59 dosing cohorts 59 candesartan 59 MIRCERA 59 gastrointestinal stromal tumor GIST 59 nucleoside reverse transcriptase inhibitor 59 randomized #:# 59 mixed dyslipidemia 59 Treanda 59 cytotoxic chemotherapy 59 SAPHRIS 59 ceftazidime 59 Flu Cy 59 Rituximab 59 Phase 2b trial 59 fluvastatin 59 celecoxib 59 Imprime PGG 59 clopidogrel 59 mg/m2/day 59 AVE# 59 angiotensin II receptor blocker 59 mcg 59 Panzem R NCD 59 Bezielle 59 novel VDA molecule 59 efficacy 59 beta 1a 59 Natalizumab 59 Campath alemtuzumab 59 non squamous NSCLC 59 COMBIVIR 59 Increlex R 59 fluticasone salmeterol 59 biologic DMARD 59 carvedilol 59 REVLIMID lenalidomide 59 Candesartan 59 virological response 59 HBeAg positive patients 59 risperidone Risperdal 59 ascending doses 59 panitumumab Vectibix 59 Keppra R 59 concomitant AEDs 59 IPX# 59 transcriptase inhibitor NNRTI 59 nicardipine 59 Peginterferon alfa 2b 59 inhaled iloprost 59 sirolimus 59 deforolimus 59 eplerenone 59 rimonabant #mg 59 interferon therapy 59 pioglitazone HCl 59 acute gout flares 59 direct renin inhibitor 59 mg RDEA# 59 ISTODAX 59 rotigotine 59 Tolvaptan 59 Camptosar ® 59 oxcarbazepine 59 natalizumab 59 Tasigna nilotinib 59 trials RCTs 59 chronic angina 59 liposomal formulation 59 ORENCIA 59 Ventavis 59 advanced hepatocellular carcinoma 59 Amigal 59 resistant ovarian cancer 59 melphalan 59 tamibarotene 59 etanercept Enbrel 59 rosuvastatin 59 ongoing Phase 1b 59 Plicera 59 ddI 59 alpha interferons 59 AVASTIN 59 JANUMET 59 Teriflunomide 59 patients evaluable 59 MGCD# [001] 59 Rituxan 59 mg qd 59 Allovectin 7 ® 59 Clolar ® 59 REMINYL ® 59 dirucotide 59 IMGN# 59 cyclophosphamide 59 FAMPYRA 59 relapsed SCLC 59 Zerenex 59 ZACTIMA 59 cetuximab Erbitux R 59 systemic corticosteroid 59 Avastin bevacizumab 59 reslizumab 59 metastatic castrate resistant 59 ONTAK 59 Rebetol 59 oral formulation 59 MGd 59 custirsen 59 VICTRELIS 59 Phase 2b clinical 59 albiglutide 59 lubiprostone 59 refractory multiple myeloma 59 LEVADEX 59 FOLFOX6 chemotherapy regimen 59 IFN alfa 59 Azilect ® 59 virus HCV protease inhibitor 59 doxorubicin 59 PRT# 59 IFN α 59 febrile neutropenia 59 Moxifloxacin 59 tizanidine 59 fluticasone propionate 59 L MTP PE 59 NNRTIs 59 candesartan cilexetil 59 cisplatin vinorelbine 59 subcutaneous insulin 59 dimebon 59 immunosuppressant 59 vorinostat 59 pitavastatin 59 rifapentine 59 Pegasys R 59 noninferior 59 NATRECOR ® 59 dosing regimen 59 registrational 59 chronic HCV infection 59 antiarrhythmic 59 Diovan HCT 59 metastatic CRC 59 CIMZIA TM certolizumab pegol 59 bronchodilator 59 antiretroviral regimen 59 PXD# 59 KAPIDEX 59 NXL# 59 serum phosphorus 59 Mitoxantrone 59 recurrent GBM 59 Lantus ® 59 #mg/day [002] 59 pimecrolimus cream 59 mometasone 59 SELZENTRY 59 ezogabine 59 rosuvastatin #mg 59 lanthanum carbonate 59 PSN# [002] 59 partial onset seizures 59 anti TNF alpha 59 FluCAM 59 Phase IIb trial 59 Pioglitazone 59 Filgrastim 59 mitomycin